Navigation Menu

Skip to Navigation menu Skip to top of page

05 January 2010

Pharma industry gets new European chief

Email a friend
  • To include more than one recipient, please seperate each email address with a semi-colon ';'


Managing Intellectual Property

EFPIA, the association that represents originator pharmaceutical companies in Europe, has appointed the CEO of GlaxoSmithKline as its president.

Andrew Witty took over from Arthur Higgins, CEO of Bayer HealthCare, on January 1. He was previously vice-president of the association.